THE NIAID DIVISION OF THE NIH CO-OWNS THE PATENT FOR THE MODERNA VACCINE, AND FOUR MEMBERS OF THE NIAID GET ROYALTIES FROM THE PROFITS INTO THEIR PERSONAL POCKETS.
THE NIAID DIVISION OF THE NIH CO-OWNS THE PATENT FOR THE MODERNA VACCINE, AND FOUR MEMBERS OF THE NIAID GET ROYALTIES FROM THE PROFITS INTO THEIR PERSONAL POCKETS.